NCT05052671View on ClinicalTrials.gov

ctDNA Assay in Patients With Resectable Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Pancreas Cancer
Trial Locations (2)

73117

RECRUITING

University of Oklahoma, Oklahoma City

74104

NOT_YET_RECRUITING

Stephenson Cancer Center- Tulsa, Tulsa

Sponsors

Collaborators (1)

Natera, Inc.
All Listed Sponsors
collaborator

Natera, Inc.

INDUSTRY

lead

University of Oklahoma

OTHER

NCT05052671 - ctDNA Assay in Patients With Resectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter